OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q4 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 700 | -50.0% | 0.00% | – |
Q4 2017 | $6,000 | +50.0% | 1,400 | +100.0% | 0.00% | – |
Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | -68.4% | 700 | -68.2% | 0.00% | -100.0% |
Q4 2016 | $19,000 | 0.0% | 2,200 | -18.5% | 0.00% | 0.0% |
Q3 2016 | $19,000 | +533.3% | 2,700 | +285.7% | 0.00% | – |
Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |